Fangda Law Firm advised Shanghai Bao Pharmaceuticals Co., Ltd. and Suzhou Centergene Pharmaceuticals Co., Ltd. on the deal. Organon China, a healthcare company with a focus...
You must be a Standard 1 Year member to access this content.
Fangda represented Kyowa Kirin on the deal. Kyowa Kirin, a global leading R&D company for innovative drugs, has reached a series of asset restructuring arrangements with...
You must be a Standard 1 Year member to access this content.
Fangda acted as legal counsel to CStone in the transaction and provided comprehensive legal services. CStone has entered into a strategic commercial collaboration with the European...
You must be a Standard 1 Year member to access this content.
Fangda advised AnHeart Therapeutics on the deal. Nuvation Bio Inc., a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and...
You must be a Standard 1 Year member to access this content.
Fangda advised SanegeneBio on the deal. Suzhou Sanegene Bio Inc. announced its strategic collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., a wholly owned subsidiary of...
You must be a Standard 1 Year member to access this content.
